Results 61 to 70 of about 1,119,241 (175)

Management of the idiopathic inflammatory myopathies

open access: yes, 2019
The idiopathic inflammatory myopathies (IIMs) – comprising polymyositis, dermatomyositis and inclusion body myositis – are a rare group of disorders characterised by muscle inflammation.
Ashraful Haque   +7 more
core   +1 more source

Top ten discoveries of the year: Neuromuscular disease

open access: yesFree Neuropathology, 2020
This review highlights ten important advances in the neuromuscular disease field that either were first reported in 2019, or have reached a broad consensus during that year.
Marta Margeta
doaj   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

TRIM Expression and Its Association With Disease Activity in Systemic Lupus Erythematosus

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse manifestations, including rash, arthritis, and nephritis. Although autoantibodies are a key feature of SLE, their levels often poorly reflect disease severity, suggesting the involvement of additional contributing factors.
Ling‐Ying Lu   +8 more
wiley   +1 more source

COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

open access: yes, 2022
We studied COVID-19 vaccination-related adverse events (ADEs) 7-days post-vaccination in patients with idiopathic inflammatory myopathies (IIMs) and other systemic autoimmune and inflammatory disorders (SAIDs)
Selva-O'Callaghan A.   +32 more
core   +1 more source

Long term functional outcome of idiopathic inflammatory myopathies

open access: yesReumatismo, 2001
The idiopathic inflammatory myopathies (IIM) comprise a group of diseases characterized by chronic inflammation of the skeletal muscles. The definition of the long-term outcome of IIM, has been limited by the difficulty in objectively evaluating the rate
R. Neri   +5 more
doaj   +1 more source

Pregnancy in CTD‐interstitial lung disease: Current evidence, clinical challenges, and a proposed management algorithm

open access: yesRheumatology &Autoimmunity, EarlyView.
Summary of pregnancy management in CTD‐ILD across preconception, antenatal, and postpartum phases, emphasizing risk stratification and multidisciplinary care. 6MWT, 6‐min walk test; CTD‐ILD: connective tissue disease‐interstitial lung disease; DLCO, diffusion capacity of the lung for carbon monoxide; FVC, forced vital capacity; MDT, multidisciplinary ...
Khaled Aldhuaina   +3 more
wiley   +1 more source

The Role of Imaging in Evaluating Patients With Idiopathic Inflammatory Myopathies [PDF]

open access: yes, 2018
OBJECTIVES: To describe imaging modalities for diagnosing and monitoring of patients with idiopathic inflammatory myopathies. METHODS: A detailed literature search summarising recent data documenting the contribution of different imaging techniques to ...
Kubínová, K   +4 more
core   +1 more source

Respiratory disorders in patients with polymyositis/dermatomyositis

open access: yesСовременная ревматология, 2014
Idiopathic inflammatory myopathies (IIM) are rare disorders characterized by inflammatory lesions in skeletal muscles. These diseases include polymyositis (PM), dermatomyositis (DM), and inclusion body myositis, which exhibit clinicoimmunological ...
Olga Alekseyevna Antelava   +3 more
doaj   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Home - About - Disclaimer - Privacy